Review paper

Dermatomyositis Flare With Immune Checkpoint Inhibitor Therapy for Melanoma

Cureus1.00
Published: Apr 9, 2021
Abstract
Immune checkpoint inhibitor (ICI) medications have seen expanded use in the management of numerous malignancies. These therapies encompass a unique spectrum of immune-related adverse events (irAEs). Rheumatological irAEs from ICIs have been described in various case reports; however, limited literature exists regarding the treatment of patients with pre-existing myositis. We describe a case of myositis flare after initiation of nivolumab for...
Paper Details
Title
Dermatomyositis Flare With Immune Checkpoint Inhibitor Therapy for Melanoma
Published Date
Apr 9, 2021
Journal
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.